The second volume of the Journal of Pharmaceutical Innovation made its debut at the ISPE 2007 Annual Meeting.  

Released 3 November to the pharmaceutical and biotechnology industries, The Journal of Pharmaceutical Innovation (JPI) includes scientific data from a panel of distinguished authors. ISPE distributes the publication quarterly to Members, along with the Society’s longtime established technical magazine, Pharmaceutical Engineering. 

JPI production is collaboration between ISPE and Springer and will be published quarterly next year. 

Share This

Genentech’s Oceanside Product Operations Facility was announced as the overall winner of the 2007 Facility of the Year (FOYA) Awards last week at ISPE’s 2007 Annual Meeting in Las Vegas, Nevada, USA.

The award program is sponsored by ISPE, a global not-for-profit association of 25,000 pharmaceutical manufacturing professionals, INTERPHEX and Pharmaceutical Processing magazine.  

Genentech’s Oceanside Facility was named the overall 2007 Facility of the Year Award winner largely due to the Design-Build Hybrid approach and people-oriented execution focus the team delivered – on time and under budget. It is a facility that features unique innovations, design advancements, and quality attributes, including large-scale modular construction (super skids), an advanced degree of automation systems, a high level of system integration, flexibility and adaptability within the manufacturing building, and expandability of each functional area. 

“This award serves as great recognition of the teamwork and quality of work of the many people who have contributed to bringing this facility on line to produce Avastin® for thousands of cancer patients,” stated David Broad, Vice President and General Manager of Genentech’s Oceanside Campus.

Share This

ISPE announced its newly elected International Board of Directors for the 2007-2008 year yesterday, 6 November, at its Annual Meeting in Las Vegas, Nevada, U.S. The Board of Directors is responsible for creating the Society’s vision, establishing its basic goals and policies, approving its financial direction and providing guidance to ISPE councils, committees, task teams, and professional staff. 

Chairman of the Board - Bruce Davis - Global Capital Director, AstraZeneca, United Kingdom  

Vice Chairman - Charles P. Hoiberg, PhD - Executive Director, Regulatory CMC - Policy and Regulatory Environment group,

Treasurer - Alan Mac Neice - Project Director for Biologics, Elan’s Biopharmaceutical Science, Athlone, Ireland 

Secretary - Andre Walker - Director of Manufacturing Engineering, Biogen Idec’s Commercial and Clinical Operations, Massachusetts, U.S.  

New Directors: Nuala Calnan - Principal Consultant, Project Management Group, Dublin, Ireland; Charlotte Enghave, PhD - Senior Consultant, Finished Product Department, NNE Pharmaplan, Soeberg, Denmark; Nigel Frost - Managing Director, Thermal Transfer Ltd., Derbyshire, United Kingdom; Damian Greene - Director/Team Leader, Pfizer Global Manufacturing (PGM), New York, U.S.; David E. Petko, PE - Senior Director, Auxilium Pharmaceuticals, Inc., Pennsylvania,

Share This